These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35383534)

  • 1. Clinical use of anti-histone antibodies in idiopathic and drug-induced lupus.
    Lee AYS
    Immunol Med; 2022 Dec; 45(4):180-185. PubMed ID: 35383534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced lupus erythematosus].
    Atzeni F; Marrazza MG; Sarzi-Puttini P; Carrabba M
    Reumatismo; 2003; 55(3):147-54. PubMed ID: 14513113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature review.
    Papadopoulou E; Saroglou M; Ismailos G; Fletsios D; Tsavlis D; Tryfon S
    Lupus; 2022 May; 31(6):650-658. PubMed ID: 35324365
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced lupus erythematosus.
    Sarzi-Puttini P; Atzeni F; Capsoni F; Lubrano E; Doria A
    Autoimmunity; 2005 Nov; 38(7):507-18. PubMed ID: 16373256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to histone in the pediatric population: a retrospective chart review.
    Justice CM; Moore TL
    Pediatr Rheumatol Online J; 2023 Apr; 21(1):40. PubMed ID: 37098546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced lupus erythematosus in childhood: Case-based review.
    Kaya Akca U; Sener S; Batu ED; Balik Z; Basaran O; Bilginer Y; Ozen S
    Lupus; 2024 Jun; 33(7):737-748. PubMed ID: 38580326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two anti-histones antibodies commercial assays in an immunology laboratory and systemic lupus erythematosus.
    Lee AYS; McDonald D; Lin MW
    J Immunol Methods; 2023 Jan; 512():113401. PubMed ID: 36473536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in systemic lupus erythematosus.
    Whittingham S
    Ann Acad Med Singap; 1988 Apr; 17(2):195-200. PubMed ID: 3044259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced lupus erythematosus: an update on drugs and mechanisms.
    He Y; Sawalha AH
    Curr Opin Rheumatol; 2018 Sep; 30(5):490-497. PubMed ID: 29870500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
    Subramanian S; Yajnik V; Sands BE; Cullen G; Korzenik JR
    Inflamm Bowel Dis; 2011 Jan; 17(1):99-104. PubMed ID: 20629183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus.
    Epstein A; Barland P
    Arthritis Rheum; 1985 Feb; 28(2):158-62. PubMed ID: 3882094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions.
    Portanova JP; Arndt RE; Tan EM; Kotzin BL
    J Immunol; 1987 Jan; 138(2):446-51. PubMed ID: 2432124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-DNA autoantibodies and systemic lupus erythematosus.
    Blatt NB; Glick GD
    Pharmacol Ther; 1999 Aug; 83(2):125-39. PubMed ID: 10511458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced lupus due to anti-tumor necrosis factor alpha agents.
    Costa MF; Said NR; Zimmermann B
    Semin Arthritis Rheum; 2008 Jun; 37(6):381-7. PubMed ID: 17977585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IgG-type antihistone antibodies. Diagnostic value in rheumatoid polyarthritis, scleroderma, spontaneous and drug-induced lupus].
    Meyer O; Cyna L; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 Jun; 51(6):303-10. PubMed ID: 6382565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.
    Sohrabian A; Parodis I; Carlströmer-Berthén N; Frodlund M; Jönsen A; Zickert A; Sjöwall C; Bengtsson AA; Gunnarsson I; Rönnelid J
    Arthritis Res Ther; 2019 Nov; 21(1):259. PubMed ID: 31783909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents.
    Dalle Vedove C; Simon JC; Girolomoni G
    J Dtsch Dermatol Ges; 2012 Dec; 10(12):889-97. PubMed ID: 22937775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.